
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link rel="preconnect" href="https://www.googletagmanager.com">
<link rel="dns-prefetch" href="https://www.google-analytics.com">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>Parkinson Disease - Neurologic Disorders - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "95464a3a-ff18-49ec-9276-e37b55bcadc7";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v1043567";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "e54ff2b0-8866-47fc-bf86-6d5cf565343a",
 VasontId : "v1043167"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "693c35da-1adf-4d55-b641-2c501365f83b",
 VasontId : "v878843"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="95464a3a-ff18-49ec-9276-e37b55bcadc7">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = '47cdd54c-07a0-4dd6-a6a2-c0495d40e10e';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 Parkinson Disease
 </h1>
 <h2 class="topic__section topic__header__headermodify--subtitle">(Parkinson's Disease)</h2>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/rajput-alex.html">Alex Rajput</a></strong>
 <p class="topic__authors--description">, MD, University of Saskatchewan;</p>
 <br>
 <strong class="topic__label topic__label--author"><a href="./Contributors/noyes-eric.html">Eric Noyes</a></strong>
 <p class="topic__authors--description">, MD, University of Saskatchewan</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised Feb 2024 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="332.0" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v1043579" class="topicmenu_mobile__paragraph">Pathophysiology</a>
 </li>
 <li>
 <a href="#v8305927" class="topicmenu_mobile__paragraph">Etiology</a>
 </li>
 <li>
 <a href="#v1043586" class="topicmenu_mobile__paragraph">Symptoms and Signs</a>
 </li>
 <li>
 <a href="#v1043627" class="topicmenu_mobile__paragraph">Diagnosis</a>
 </li>
 <li>
 <a href="#v1043652" class="topicmenu_mobile__paragraph">Treatment</a>
 </li>
 <li>
 <a href="#v8306009" class="topicmenu_mobile__paragraph">Key Points</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Biodigitals'); }, keypress: function() { $data.activateGroup('Biodigitals'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 3D Models (2)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--biodigital" data-group-name="biodigital" title="Basal Ganglia: Coronal Section">
 <div class="">
 <img class="--image" src="./~/media/manual/professional/images/b/i/o/biodigital-basal-ganglia-coronal-pv-sized.jpg?thn=0&sc_lang=en" width="242" height="129" loading="lazy">
 </div>
 <span class="hero__description">
 Basal Ganglia: Coronal Section
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"https://human.biodigital.com/widget/?be=2grM\u0026background.colors=0,0,0,1,0,0,0,1\u0026initial.hand-hint=true\u0026ui-fullscreen=true\u0026ui-center=false\u0026ui-dissect=true\u0026ui-zoom=true\u0026ui-help=true\u0026ui-tools-display=primary\u0026ui-info=true\u0026uaid=3UHus","ItemId":"9d253909-2d24-4e6a-8c77-ba6f48d47b65","Title":"Basal%20Ganglia%3A%20Coronal%20Section","ShareUrlTitle":"basal-ganglia-coronal-section","Description":"","ImageUrl":"./~/media/manual/professional/images/b/i/o/biodigital-basal-ganglia-coronal-pv-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/b/i/o/biodigital-basal-ganglia-coronal-pv-sized.jpg?thn=0\u0026sc_lang=en","MediaType":"biodigital","MediaNameTranslated":"3D%20Model","UniqueId":"v42138256","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"242","ImageHeight":"129","Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Basal%20Ganglia%3A%20Coronal%20Section","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%203D%20Model","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--biodigital" data-group-name="biodigital" title="Basal Ganglia: Regional Dissection">
 <div class="">
 <img class="--image" src="./~/media/manual/professional/images/b/i/o/biodigital-basal-ganglia-dissection-pv-sized.jpg?thn=0&sc_lang=en" width="242" height="129" loading="lazy">
 </div>
 <span class="hero__description">
 Basal Ganglia: Regional Dissectio...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"https://human.biodigital.com/widget/?be=2grW\u0026background.colors=0,0,0,1,0,0,0,1\u0026initial.hand-hint=true\u0026ui-info=true\u0026ui-fullscreen=true\u0026ui-center=false\u0026ui-dissect=true\u0026ui-zoom=true\u0026ui-help=true\u0026ui-tools-display=primary\u0026uaid=3UIHf","ItemId":"c5f85634-c514-483a-9c40-c86dfdf9306e","Title":"Basal%20Ganglia%3A%20Regional%20Dissection","ShareUrlTitle":"basal-ganglia-regional-dissection","Description":"","ImageUrl":"./~/media/manual/professional/images/b/i/o/biodigital-basal-ganglia-dissection-pv-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/b/i/o/biodigital-basal-ganglia-dissection-pv-sized.jpg?thn=0\u0026sc_lang=en","MediaType":"biodigital","MediaNameTranslated":"3D%20Model","UniqueId":"v42138264","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"242","ImageHeight":"129","Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Basal%20Ganglia%3A%20Regional%20Dissection","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%203D%20Model","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Calculators (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Images'); }, keypress: function() { $data.activateGroup('Images'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Images (1)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Basal Ganglia">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/n/e/u/neu-basal-ganglia.gif?mw=350&amp;thn=0&amp;sc_lang=en" width="595" height="413" loading="lazy">
 </div>
 <span class="hero__description">
 Basal Ganglia
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Basal Ganglia","Credits":"","IsRestricted":false,"ItemId":"6c21f44c-8750-42c2-a138-c9b19df345f1","Title":"Basal%20Ganglia","ShareUrlTitle":"basal-ganglia","Description":"","ImageUrl":"./~/media/manual/professional/images/n/e/u/neu-basal-ganglia.gif?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/n/e/u/neu-basal-ganglia.gif?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"NEU-basal-ganglia.ai","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"595","ImageHeight":"413","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Basal%20Ganglia","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Tables (1)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Some Commonly Used Oral Antiparkinsonian Medications">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Some Commonly Used Oral Antiparki...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"cbf7ac9e-faca-457d-89eb-a8fe5c5c608e","Title":"Some%20Commonly%20Used%20Oral%20Antiparkinsonian%20Medications","ShareUrlTitle":"some-commonly-used-oral-antiparkinsonian-medications","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55490836","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Some%20Commonly%20Used%20Oral%20Antiparkinsonian%20Medications","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v1469065" class="anchor"></span><div class="para"> <p><div class='topic__explanation'>Parkinson disease is a slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity), slow and decreased movement (bradykinesia), and eventually gait and/or postural instability. Diagnosis is clinical. Treatment aims to restore dopaminergic function in the brain with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carbidopa</span> and/or other medications (eg, <span class="genericDrug" data-showrollover="false">dopamine</span> agonists, monoamine oxidase type B [MAO-B] inhibitors, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>amantadine</span>). For refractory symptoms in patients without dementia, stereotactic deep brain stimulation or lesional surgery and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span> and an <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apomorphine</span> pump may help.</div></p></div><span id="v29590224" class="anchor"></span><div class="para"> <p>(See also <a href="./{CCC1358B-7A5C-4DB1-A96E-A9B74D7CB35C}.html" data-toggle="tooltip" title="Overview of Movement and Cerebellar Disorders" data-id="2c54b15e-e174-432e-bf27-8937b56c928c" data-itemid="ccc1358b-7a5c-4db1-a96e-a9b74d7cb35c">Overview of Movement and Cerebellar Disorders</a><span id="2c54b15e-e174-432e-bf27-8937b56c928c" class="d-none xref"> <span class="tooltip-container"> <a href="./{CCC1358B-7A5C-4DB1-A96E-A9B74D7CB35C}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Movement and Cerebellar Disorders </span> Voluntary movement requires complex interaction of the corticospinal (pyramidal) tracts, basal ganglia, and cerebellum (the center for motor coordination) to ensure smooth, purposeful movement... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>.)</p></div><span id="v1043577" class="anchor"></span><div class="para"> <p>The prevalence of Parkinson disease in North America is approximately 0.6% in adults age ≥ 45;prevalence increases with age (<a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v88079776" data-toggle="tooltip" title="General references" data-id="13eb158d-240c-4af2-bb00-44b86a06ff4f" data-itemid="95464a3a-ff18-49ec-9276-e37b55bcadc7">1</a><span id="13eb158d-240c-4af2-bb00-44b86a06ff4f" class="d-none xref"> <span class="tooltip-container"> <a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v88079776"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Parkinson disease is a slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity), slow and decreased movement (bradykinesia), and eventually gait and/or... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v21505053" class="anchor"></span><div class="para"> <p>The mean age at onset is approximately 6 years. Patients with tremor-dominant disease may develop motor symptoms earlier than those with akinetic-rigid disease (<a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v88079776" data-toggle="tooltip" title="General references" data-id="16fe5be2-5599-4f7d-adbe-3f41c0c9392f" data-itemid="95464a3a-ff18-49ec-9276-e37b55bcadc7">2</a><span id="16fe5be2-5599-4f7d-adbe-3f41c0c9392f" class="d-none xref"> <span class="tooltip-container"> <a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v88079776"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Parkinson disease is a slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity), slow and decreased movement (bradykinesia), and eventually gait and/or... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v8305924" class="anchor"></span><div class="para"> <p>Parkinson disease is usually idiopathic.</p></div><span id="v21505054" class="anchor"></span><div class="para"> <p><b>Juvenile parkinsonism,</b> which is rare, begins during childhood or adolescence up to 20 years. Onset between ages 21 and 40 years is sometimes called young or early-onset Parkinson disease. Genetic causes are more likely in juvenile and early-onset Parkinson disease; these forms may differ from later-onset Parkinson disease because </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v41282673" class="anchor"></span><div class="para"> <p>They progress more slowly.</p></div></li><li class="topic__listitem"><span id="v41282675" class="anchor"></span><div class="para"> <p>They are very sensitive to dopaminergic treatments.</p></div></li><li class="topic__listitem"><span id="v41282677" class="anchor"></span><div class="para"> <p>Most disability results from nonmotor symptoms such as depression, anxiety, and pain.</p></div></li></ul></div><span id="v1043578" class="anchor"></span><div class="para"> <p><b> <a href="./{670C3BCD-FC33-45EC-8533-50441F1E9E1C}.html" data-toggle="tooltip" title="Secondary and Atypical Parkinsonism" data-id="68c7ea6b-5f0a-46bd-a70a-2d19c4ff6e2b" data-itemid="670c3bcd-fc33-45ec-8533-50441f1e9e1c">Secondary parkinsonism</a><span id="68c7ea6b-5f0a-46bd-a70a-2d19c4ff6e2b" class="d-none xref"> <span class="tooltip-container"> <a href="./{670C3BCD-FC33-45EC-8533-50441F1E9E1C}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Secondary and Atypical Parkinsonism </span> Secondary parkinsonism refers to a group of disorders that have features similar to those of Parkinson disease but have a different etiology. Atypical parkinsonism refers to a group of neurodegenerative... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></b> is brain dysfunction that is characterized by basal ganglia dopaminergic blockade and that is similar to Parkinson disease, but it is caused by something other than Parkinson disease (eg, medications, cerebrovascular disease, trauma, postencephalitic changes).</p></div><span id="v21505056" class="anchor"></span><div class="para"> <p><b> <a href="./{670C3BCD-FC33-45EC-8533-50441F1E9E1C}.html" data-toggle="tooltip" title="Secondary and Atypical Parkinsonism" data-id="c9b0734a-8e65-4d92-8cf8-6f9d215b7671" data-itemid="670c3bcd-fc33-45ec-8533-50441f1e9e1c">Atypical parkinsonism</a><span id="c9b0734a-8e65-4d92-8cf8-6f9d215b7671" class="d-none xref"> <span class="tooltip-container"> <a href="./{670C3BCD-FC33-45EC-8533-50441F1E9E1C}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Secondary and Atypical Parkinsonism </span> Secondary parkinsonism refers to a group of disorders that have features similar to those of Parkinson disease but have a different etiology. Atypical parkinsonism refers to a group of neurodegenerative... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></b> refers to a group of neurodegenerative disorders that have some features similar to those of Parkinson disease but have some different clinical features, a worse prognosis, a modest or no response to <span class="genericDrug" data-showrollover="false">levodopa</span>, and a different pathology (eg, neurodegenerative disorders such as <a href="./{C6B99E36-C166-47AB-A1FD-460CE2A1A5F6}.html" data-toggle="tooltip" title="Multiple System Atrophy (MSA)" data-id="25b9d867-6e4b-4fef-b493-e00c48cb5127" data-itemid="c6b99e36-c166-47ab-a1fd-460ce2a1a5f6">multiple system atrophy</a><span id="25b9d867-6e4b-4fef-b493-e00c48cb5127" class="d-none xref"> <span class="tooltip-container"> <a href="./{C6B99E36-C166-47AB-A1FD-460CE2A1A5F6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Multiple System Atrophy (MSA) </span> Multiple system atrophy is a relentlessly progressive neurodegenerative disorder causing pyramidal, cerebellar, and autonomic dysfunction. It includes 3 disorders previously thought to be distinct... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{3C4DA3C4-FC36-46E0-84E1-6398A385289C}.html" data-toggle="tooltip" title="Progressive Supranuclear Palsy (PSP)" data-id="fbbe3dbc-4ce3-453c-9a0c-93510f686b6d" data-itemid="3c4da3c4-fc36-46e0-84e1-6398a385289c">progressive supranuclear palsy</a><span id="fbbe3dbc-4ce3-453c-9a0c-93510f686b6d" class="d-none xref"> <span class="tooltip-container"> <a href="./{3C4DA3C4-FC36-46E0-84E1-6398A385289C}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Progressive Supranuclear Palsy (PSP) </span> Progressive supranuclear palsy is a rare, degenerative central nervous system disorder that progressively impairs voluntary eye movements and causes bradykinesia, muscular rigidity with progressive... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/3/c0365222-progressive-supranuclear-palsy-psp-mri-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Progressive Supranuclear Palsy (PSP)" loading="lazy"> </span> </a> </span> </span>, <a href="./{BF481761-601E-410A-A819-7E671DAFA637}.html" data-toggle="tooltip" title="Dementia with Lewy Bodies and Parkinson Disease Dementia" data-id="8e24fdce-a6a6-42f5-a8aa-2029794934f0" data-itemid="bf481761-601e-410a-a819-7e671dafa637">dementia with Lewy bodies</a><span id="8e24fdce-a6a6-42f5-a8aa-2029794934f0" class="d-none xref"> <span class="tooltip-container"> <a href="./{BF481761-601E-410A-A819-7E671DAFA637}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Dementia with Lewy Bodies and Parkinson Disease Dementia </span> Lewy body dementia includes clinically diagnosed dementia with Lewy bodies and Parkinson disease dementia. Dementia with Lewy bodies is chronic cognitive deterioration characterized by cellular... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, and corticobasal ganglionic degeneration).</p></div> <section id="v88079775" class="topic__section GHead"> <span></span> <h2 id="" class="topic__header--section"> <span id="v88079776" class="anchor"></span> General references </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v88079779" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.nature.com/articles/s41531-022-00410-y">Willis AW, Roberts E , Beck JC, et al</a>: Incidence of Parkinson disease in North America. <span data-mmanualobjecttype="pubtitle">NPJ Parkinsons Dis</span> 8 (1):170, 2022. doi: 10.1038/s41531-022-00410-y</p></div></li><li class="topic__listitem"><span id="v88079783" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.neurology.org/doi/10.1212/WNL.0b013e3181ae7af1?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed">Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A</a>: Course in Parkinson disease subtypes: A 39-year clinicopathologic study. <span data-mmanualobjecttype="pubtitle">Neurology</span> 73 (3):206–212, 2009. doi: 10.1212/WNL.0b013e3181ae7af1</p></div></li></ul></div> </div> </section> <section id="v1043579" class="topic__section FHead" itemprop="cause" itemscope="" itemtype="http://schema.org/MedicalCause"> <h2 id="Etiology_v1043580" class="topic__header--section" data-originaltitle="Pathophysiology"> <span id="v1043580" class="anchor"></span> Pathophysiology of Parkinson Disease </h2> <div class="topic__content"> <span id="v1043581" class="anchor"></span><div class="para"> <p>Synuclein is primarily a neuronal cell protein that can aggregate into insoluble fibrils and form Lewy bodies.</p></div><span id="v21505058" class="anchor"></span><div class="para"> <p>The <b>pathologic hallmark of sporadic or idiopathic Parkinson disease</b> is </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v21505061" class="anchor"></span><div class="para"> <p>Synuclein-filled Lewy bodies in the nigrostriatal system</p></div></li></ul></div><span id="v21505062" class="anchor"></span><div class="para"> <p>However, synuclein can accumulate in many other parts of the nervous system, including the dorsal motor nucleus of the vagus nerve, basal nucleus of Meynert, hypothalamus, neocortex, olfactory bulb, sympathetic ganglia, and myenteric plexus of the gastrointestinal tract. Lewy bodies appear in a temporal sequence, and many experts believe that Parkinson disease is a relatively late development in a systemic synucleinopathy. Other synucleinopathies (synuclein deposition disorders) include <a href="./{BF481761-601E-410A-A819-7E671DAFA637}.html" data-toggle="tooltip" title="Dementia with Lewy Bodies and Parkinson Disease Dementia" data-id="e6a463bd-fbb7-4c68-9805-3c22f3fb2c01" data-itemid="bf481761-601e-410a-a819-7e671dafa637">dementia with Lewy bodies</a><span id="e6a463bd-fbb7-4c68-9805-3c22f3fb2c01" class="d-none xref"> <span class="tooltip-container"> <a href="./{BF481761-601E-410A-A819-7E671DAFA637}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Dementia with Lewy Bodies and Parkinson Disease Dementia </span> Lewy body dementia includes clinically diagnosed dementia with Lewy bodies and Parkinson disease dementia. Dementia with Lewy bodies is chronic cognitive deterioration characterized by cellular... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and <a href="./{C6B99E36-C166-47AB-A1FD-460CE2A1A5F6}.html" data-toggle="tooltip" title="Multiple System Atrophy (MSA)" data-id="0b351f72-8cdf-4457-b34f-559dc7e21e77" data-itemid="c6b99e36-c166-47ab-a1fd-460ce2a1a5f6">multiple system atrophy</a><span id="0b351f72-8cdf-4457-b34f-559dc7e21e77" class="d-none xref"> <span class="tooltip-container"> <a href="./{C6B99E36-C166-47AB-A1FD-460CE2A1A5F6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Multiple System Atrophy (MSA) </span> Multiple system atrophy is a relentlessly progressive neurodegenerative disorder causing pyramidal, cerebellar, and autonomic dysfunction. It includes 3 disorders previously thought to be distinct... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Parkinson disease may share features of other synucleinopathies, such as autonomic dysfunction and dementia.</p></div><span id="v1043584" class="anchor"></span><div class="para"> <p>Rarely, Parkinson disease occurs without Lewy bodies (eg, in a form due to a mutation in the <i data-mmanualobjecttype='gene' '>PARK 2</i> gene).</p></div><span id="v8305926" class="anchor"></span><div class="para"> <p>In Parkinson disease, pigmented neurons of the substantia nigra, locus ceruleus, and other brain stem dopaminergic cell groups degenerate. Loss of substantia nigra neurons results in depletion of <span class="genericDrug" data-showrollover="false">dopamine</span> in the dorsal aspect of the putamen (part of the basal ganglia) and causes many of the motor manifestations of Parkinson disease (see figure <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"Alt":"Basal Ganglia","Credits":"","IsRestricted":false,"ItemId":"6c21f44c-8750-42c2-a138-c9b19df345f1","Title":"Basal%20Ganglia","ShareUrlTitle":"basal-ganglia","Description":"","ImageUrl":"/-/media/manual/professional/images/n/e/u/neu-basal-ganglia.gif?thn=0\u0026sc_lang=en","ThumbnailUrl":"/-/media/manual/professional/images/n/e/u/neu-basal-ganglia.gif?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"NEU-basal-ganglia.ai","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"595","ImageHeight":"413","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EBasal%20Ganglia%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>).</p></div> <span id="v55490530"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--figure "> <div class="inlinebox__wrapper"> <div class="inlinebox__content"> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v29590044"></span> <div class="FigureFullPage" id="v55490531"> <h3 class="title">Basal Ganglia</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td> <div class="inlinemedia__container"> <div class="inlinemedia__image--container"> <img oncontextmenu="return false;" data-mmanualobjecttype="Image" src="./~/media/manual/professional/images/n/e/u/neu-basal-ganglia.gif?thn=0&sc_lang=en" alt="Basal Ganglia" lang="" loading="lazy" height="413" width="595"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Basal Ganglia","Credits":"","IsRestricted":false,"ItemId":"6c21f44c-8750-42c2-a138-c9b19df345f1","Title":"Basal%20Ganglia","ShareUrlTitle":"basal-ganglia","Description":"","ImageUrl":"./~/media/manual/professional/images/n/e/u/neu-basal-ganglia.gif?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/n/e/u/neu-basal-ganglia.gif?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"NEU-basal-ganglia.ai","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"595","ImageHeight":"413","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"","LinkText":"Basal%20Ganglia","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":true,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> </div> </div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div> <div> </div> </div> </div> <!-- Type: Figure --> </div> <div class="inlinemedia-component " data-ko-rebind="v42138256" data-bind="component: {name: 'inlinemedia-biodigital', params: $data}" data-inline-model='{"IframeSrc":"https://human.biodigital.com/widget/?be=2grM\u0026background.colors=0,0,0,1,0,0,0,1\u0026initial.hand-hint=true\u0026ui-fullscreen=true\u0026ui-center=false\u0026ui-dissect=true\u0026ui-zoom=true\u0026ui-help=true\u0026ui-tools-display=primary\u0026ui-info=true\u0026uaid=3UHus","ItemId":"9d253909-2d24-4e6a-8c77-ba6f48d47b65","Title":"Basal Ganglia: Coronal Section","ShareUrlTitle":"basal-ganglia-coronal-section","Description":"","ImageUrl":"./~/media/manual/professional/images/b/i/o/biodigital-basal-ganglia-coronal-pv-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/b/i/o/biodigital-basal-ganglia-coronal-pv-sized.jpg?thn=0\u0026sc_lang=en","MediaType":"biodigital","MediaNameTranslated":"3D Model","UniqueId":"v42138256","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"242","ImageHeight":"129","Target":null,"Alt":null}'> </div> <div class="inlinemedia-component " data-ko-rebind="v42138264" data-bind="component: {name: 'inlinemedia-biodigital', params: $data}" data-inline-model='{"IframeSrc":"https://human.biodigital.com/widget/?be=2grW\u0026background.colors=0,0,0,1,0,0,0,1\u0026initial.hand-hint=true\u0026ui-info=true\u0026ui-fullscreen=true\u0026ui-center=false\u0026ui-dissect=true\u0026ui-zoom=true\u0026ui-help=true\u0026ui-tools-display=primary\u0026uaid=3UIHf","ItemId":"c5f85634-c514-483a-9c40-c86dfdf9306e","Title":"Basal Ganglia: Regional Dissection","ShareUrlTitle":"basal-ganglia-regional-dissection","Description":"","ImageUrl":"./~/media/manual/professional/images/b/i/o/biodigital-basal-ganglia-dissection-pv-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/b/i/o/biodigital-basal-ganglia-dissection-pv-sized.jpg?thn=0\u0026sc_lang=en","MediaType":"biodigital","MediaNameTranslated":"3D Model","UniqueId":"v42138264","Placement":"inline","IsInCarousel":false,"Edition":0,"ImageWidth":"242","ImageHeight":"129","Target":null,"Alt":null}'> </div> </div> </section> <section id="v8305927" class="topic__section FHead" itemprop="cause" itemscope="" itemtype="http://schema.org/MedicalCause"> <h2 id="" class="topic__header--section" data-originaltitle="Etiology"> <span id="v8305928" class="anchor"></span> Etiology of Parkinson Disease </h2> <div class="topic__content"> <span id="v8305929" class="anchor"></span><div class="para"> <p>Although Parkinson disease was initially considered sporadic, accumulating evidence suggests that Parkinson disease has a substantial genetic component, probably causing or influencing at least 10 to 25% of cases, more commonly in younger patients (<a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v88079792" data-toggle="tooltip" title="Etiology reference" data-id="d23329d2-1c36-4759-9ba5-e553b9c62ccd" data-itemid="95464a3a-ff18-49ec-9276-e37b55bcadc7">1</a><span id="d23329d2-1c36-4759-9ba5-e553b9c62ccd" class="d-none xref"> <span class="tooltip-container"> <a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v88079792"> <span class="tooltip-content"> <span class="tooltip-heading"> Etiology reference </span> Parkinson disease is a slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity), slow and decreased movement (bradykinesia), and eventually gait and/or... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). The frequency of genetic mutations varies by ethnicity. </p></div><span id="v88079787" class="anchor"></span><div class="para"> <p>Worldwide, mutations in <i data-mmanualobjecttype='gene' '>LRRK2</i> encoding for leucine-rich repeat protein kinase 2) and <i data-mmanualobjecttype='gene' '>GBA</i> (encoding for glucocerebrosidase), which are the two most common genetic determinants of Parkinson disease. Mutations, duplications, or triplications in the gene for alpha-synuclein are very rare, familial cases of Parkinson disease.</p></div><span id="v88079790" class="anchor"></span><div class="para"> <p>Environmental risk factors include exposure to carbon monoxide, pesticide use, and chronic consumption of well water. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Caffeine</span> intake, smoking, and physical activity predict lower risk.</p></div> <section id="v88079791" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalCause"></span> <h3 id="" class="topic__header--subsection"> <span itemprop="name" id="v88079792" class="anchor"></span> Etiology reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v88079795" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578399/">Singleton AB, Farrer MJ, Bonifati V</a>: The genetics of Parkinson’s disease: Progress and therapeutic implications. <span data-mmanualobjecttype="pubtitle">Mov Disord</span> 28 (1):14–23, 2013. doi: 10.1002/mds.25249</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1043586" class="topic__section FHead"> <h2 id="SymptomsAndSigns_v1043587" class="topic__header--section" data-originaltitle="Symptoms and Signs"> <span id="v1043587" class="anchor"></span> Symptoms and Signs of Parkinson Disease </h2> <div class="topic__content"> <span id="v1043588" class="anchor"></span><div class="para"> <p>In most patients, symptoms of Parkinson disease begin insidiously.</p></div><span id="v1043590" class="anchor"></span><div class="para"> <p>A <b>resting tremor</b> of one hand is often the first symptom. The tremor is characterized as follows:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1043593" class="anchor"></span><div class="para"> <p>Slow and coarse</p></div></li><li class="topic__listitem"><span id="v1043595" class="anchor"></span><div class="para"> <p>Maximal at rest, lessening during movement, and absent during sleep</p></div></li><li class="topic__listitem"><span id="v1043597" class="anchor"></span><div class="para"> <p>Amplitude increased by emotional tension or fatigue</p></div></li><li class="topic__listitem"><span id="v1043599" class="anchor"></span><div class="para"> <p>Often involving the wrist and fingers, sometimes involving the thumb moving against the index finger (pill rolling), as when people roll a pill in their hand or handle a small object</p></div></li></ul></div><span id="v1043600" class="anchor"></span><div class="para"> <p>Usually, the hands or feet are affected first, most often asymmetrically. The jaw and tongue may also be affected, but not the voice. However, speech may become hypophonic, with characteristic monotonous, sometimes stuttering dysarthria. Tremor may become less prominent as rigidity progresses. In predominantly rigid-akinetic forms of Parkinson disease, resting tremor is subtle or absent.</p></div><span id="v1043601" class="anchor"></span><div class="para" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <p><b>Rigidity</b> develops independently of tremor in many patients. When a clinician moves a rigid joint, semirhythmic jerks occur because the intensity of the rigidity varies, causing a ratchet-like effect (cogwheel rigidity).</p></div><span id="v1043603" class="anchor"></span><div class="para" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <p><b>Slow movements</b> (bradykinesia) are typical in Parkinson disease. Repetitive motor activity results in a progressive or sustained decrease in amplitude of movement (hypokinesia), and movement becomes hard to initiate (akinesia).</p></div><span id="v1043607" class="anchor"></span><div class="para"> <p>Rigidity and hypokinesia may contribute to muscle aches and sensations of fatigue. The face becomes masklike (hypomimic), with an open mouth and reduced blinking. Excessive drooling (sialorrhea) may contribute to disability.</p></div><span id="v21505065" class="anchor"></span><div class="para"> <p>Hypokinesia and impaired control of distal muscles cause micrographia (writing in very small letters) and make activities of daily living increasingly difficult.</p></div><span id="v1043609" class="anchor"></span><div class="para" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <p><b>Postural instability</b> may develop later in Parkinson disease; if present at disease onset, alternative diagnoses should be suspected. Patients have difficulty starting to walk, turning, and stopping. They shuffle, taking short steps, holding their arms flexed to the waist, and swinging their arms little or not at all with each stride. Steps may inadvertently quicken, while stride length progressively shortens; this gait abnormality, called festination, is often a precursor to freezing of gait (when, without warning, walking and other voluntary movements may suddenly halt). A tendency to fall forward (propulsion) or backward (retropulsion) when the center of gravity is displaced results from loss of postural reflexes. Posture becomes stooped.</p></div><span id="v1043611" class="anchor"></span><div class="para" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <p><b>Dementia</b> develops in about one third of patients, usually late in Parkinson disease. Early predictors of its development are visuospatial impairment (eg, getting lost while driving) and decreased verbal fluency.</p></div><span id="v1043613" class="anchor"></span><div class="para" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <p><b>Sleep disorders</b> are common. Insomnia may result from nocturia or from the inability to turn in bed. Sleep deprivation may exacerbate depression and cognitive impairment and contribute to excessive daytime sleepiness. <a href="./{A9F3228E-3D12-4FEB-B801-F03BD38D4BFD}.html#v1039586" data-toggle="tooltip" title="Rapid eye movement (REM) sleep behavior disorder" data-id="d4edb457-4ce4-490b-bbf9-87330f7e3922" data-itemid="a9f3228e-3d12-4feb-b801-f03bd38d4bfd">Rapid eye movement (REM) sleep behavior disorder</a><span id="d4edb457-4ce4-490b-bbf9-87330f7e3922" class="d-none xref"> <span class="tooltip-container"> <a href="./{A9F3228E-3D12-4FEB-B801-F03BD38D4BFD}.html#v1039586"> <span class="tooltip-content"> <span class="tooltip-heading"> Rapid eye movement (REM) sleep behavior disorder </span> Parasomnias are undesirable behaviors that occur during entry into sleep, during sleep, or during arousal from sleep. Diagnosis is clinical. Treatment may include drugs and psychotherapy. (See... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> may develop; in this disorder, verbalization and uncontrollable, possibly violent limb movements occur during REM sleep because the paralysis that normally occurs during REM sleep is absent. <a href="./{A9F3228E-3D12-4FEB-B801-F03BD38D4BFD}.html#v1039586" data-toggle="tooltip" title="Rapid eye movement (REM) sleep behavior disorder" data-id="d7776b0e-f3fa-4c0b-aff2-8ed8fb511a91" data-itemid="a9f3228e-3d12-4feb-b801-f03bd38d4bfd">REM sleep behavior disorder</a><span id="d7776b0e-f3fa-4c0b-aff2-8ed8fb511a91" class="d-none xref"> <span class="tooltip-container"> <a href="./{A9F3228E-3D12-4FEB-B801-F03BD38D4BFD}.html#v1039586"> <span class="tooltip-content"> <span class="tooltip-heading"> Rapid eye movement (REM) sleep behavior disorder </span> Parasomnias are undesirable behaviors that occur during entry into sleep, during sleep, or during arousal from sleep. Diagnosis is clinical. Treatment may include drugs and psychotherapy. (See... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> is often accompanied by early neurodegenerative signs that occur primarily in patients with alpha-synucleinopathies, which can precede and/or increase the risk of developing Parkinson disease, <a href="./{C6B99E36-C166-47AB-A1FD-460CE2A1A5F6}.html" data-toggle="tooltip" title="Multiple System Atrophy (MSA)" data-id="d1b6ab7d-0c5c-44f5-aaa4-f1b5af6f9d62" data-itemid="c6b99e36-c166-47ab-a1fd-460ce2a1a5f6">multiple system atrophy</a><span id="d1b6ab7d-0c5c-44f5-aaa4-f1b5af6f9d62" class="d-none xref"> <span class="tooltip-container"> <a href="./{C6B99E36-C166-47AB-A1FD-460CE2A1A5F6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Multiple System Atrophy (MSA) </span> Multiple system atrophy is a relentlessly progressive neurodegenerative disorder causing pyramidal, cerebellar, and autonomic dysfunction. It includes 3 disorders previously thought to be distinct... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, or <a href="./{BF481761-601E-410A-A819-7E671DAFA637}.html" data-toggle="tooltip" title="Dementia with Lewy Bodies and Parkinson Disease Dementia" data-id="83fca5f0-9089-45c4-87e8-d31f4782da3e" data-itemid="bf481761-601e-410a-a819-7e671dafa637">dementia with Lewy bodies</a><span id="83fca5f0-9089-45c4-87e8-d31f4782da3e" class="d-none xref"> <span class="tooltip-container"> <a href="./{BF481761-601E-410A-A819-7E671DAFA637}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Dementia with Lewy Bodies and Parkinson Disease Dementia </span> Lewy body dementia includes clinically diagnosed dementia with Lewy bodies and Parkinson disease dementia. Dementia with Lewy bodies is chronic cognitive deterioration characterized by cellular... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. </p></div><span id="v1043615" class="anchor"></span><div class="para" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <p><b>Neurologic symptoms unrelated to parkinsonism</b> commonly develop because synucleinopathy occurs in other areas of the central, peripheral, and autonomic nervous systems. The following are examples:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1043618" class="anchor"></span><div class="para"> <p>Almost universal sympathetic denervation of the heart, contributing to <a href="./{E13E2DEC-3994-4ABB-A0BE-891827685991}.html" data-toggle="tooltip" title="Orthostatic Hypotension" data-id="fe6f5af8-90fd-4d4e-89a0-7aafb9194c15" data-itemid="e13e2dec-3994-4abb-a0be-891827685991">orthostatic hypotension</a><span id="fe6f5af8-90fd-4d4e-89a0-7aafb9194c15" class="d-none xref"> <span class="tooltip-container"> <a href="./{E13E2DEC-3994-4ABB-A0BE-891827685991}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Orthostatic Hypotension </span> Orthostatic (postural) hypotension is an excessive fall in blood pressure (BP) when an upright position is assumed. The consensus definition is a drop of > 20 mm Hg systolic, > 10 mm Hg... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v1043620" class="anchor"></span><div class="para"> <p>Esophageal dysmotility, contributing to <a href="./{9B72AE77-EC13-4B29-90A5-1FBA5EC21FFE}.html" data-toggle="tooltip" title="Dysphagia" data-id="86fed2a7-ef94-4ebd-a83d-56033ba2c507" data-itemid="9b72ae77-ec13-4b29-90a5-1fba5ec21ffe">dysphagia</a><span id="86fed2a7-ef94-4ebd-a83d-56033ba2c507" class="d-none xref"> <span class="tooltip-container"> <a href="./{9B72AE77-EC13-4B29-90A5-1FBA5EC21FFE}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Dysphagia </span> Dysphagia is difficulty swallowing. The condition results from impeded transport of liquids, solids, or both from the pharynx to the stomach. Dysphagia should not be confused with globus sensation... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and increased risk of aspiration</p></div></li><li class="topic__listitem"><span id="v1043622" class="anchor"></span><div class="para"> <p>Lower bowel dysmotility, contributing to <a href="./{E4AFEB94-FC5E-4A03-BF5E-3BCE098D8EE7}.html" data-toggle="tooltip" title="Constipation" data-id="44abb727-9ee5-47a7-9f11-d152f455266c" data-itemid="e4afeb94-fc5e-4a03-bf5e-3bce098d8ee7">constipation</a><span id="44abb727-9ee5-47a7-9f11-d152f455266c" class="d-none xref"> <span class="tooltip-container"> <a href="./{E4AFEB94-FC5E-4A03-BF5E-3BCE098D8EE7}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Constipation </span> Constipation is difficult or infrequent passage of stool, hardness of stool, or a feeling of incomplete evacuation. (See also Constipation in Children.) No bodily function is more variable and... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v1043624" class="anchor"></span><div class="para"> <p>Urinary hesitancy and/or urgency, potentially leading to <a href="./{D4A51C7B-C445-4250-8447-DE3B1B20F0E8}.html" data-toggle="tooltip" title="Urinary Incontinence in Adults" data-id="b34997d2-4583-48b1-a31a-79f7b96488dd" data-itemid="d4a51c7b-c445-4250-8447-de3b1b20f0e8">incontinence</a><span id="b34997d2-4583-48b1-a31a-79f7b96488dd" class="d-none xref"> <span class="tooltip-container"> <a href="./{D4A51C7B-C445-4250-8447-DE3B1B20F0E8}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Urinary Incontinence in Adults </span> Urinary incontinence is involuntary loss of urine; some experts consider it present only when a patient thinks it is a problem. The disorder is greatly underrecognized and underreported. Many... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (common)</p></div></li><li class="topic__listitem"><span id="v1469086" class="anchor"></span><div class="para"> <p> <a href="./{FC0E3F35-4E4B-4B27-8ACB-DCF7ECDF723D}.html" data-toggle="tooltip" title="Anosmia" data-id="13528483-8eee-4047-b785-88c431879ae6" data-itemid="fc0e3f35-4e4b-4b27-8acb-dcf7ecdf723d">Anosmia</a><span id="13528483-8eee-4047-b785-88c431879ae6" class="d-none xref"> <span class="tooltip-container"> <a href="./{FC0E3F35-4E4B-4B27-8ACB-DCF7ECDF723D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Anosmia </span> Anosmia is complete loss of smell. Hyposmia is partial loss of smell. If unilateral, anosmia is often unrecognized. Most patients with anosmia have normal perception of salty, sweet, sour, and... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (common)</p></div></li></ul></div><span id="v1043625" class="anchor"></span><div class="para"> <p>In some patients, some of these symptoms occur before the motor symptoms of Parkinson disease and frequently worsen over time.</p></div><span id="v8305930" class="anchor"></span><div class="para" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <p><b> <a href="./{79460D4D-B36B-4D2C-A83F-5E3E186F4A76}.html" data-toggle="tooltip" title="Seborrheic Dermatitis" data-id="cd312c95-b85c-4042-a9b5-1ff19b09b62f" data-itemid="79460d4d-b36b-4d2c-a83f-5e3e186f4a76">Seborrheic dermatitis</a><span id="cd312c95-b85c-4042-a9b5-1ff19b09b62f" class="d-none xref"> <span class="tooltip-container"> <a href="./{79460D4D-B36B-4D2C-A83F-5E3E186F4A76}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Seborrheic Dermatitis </span> Seborrheic dermatitis is a common inflammatory condition of skin regions with a high density of sebaceous glands (eg, face, scalp, sternum). The cause is unknown, but species of <i>Malassezia</i>... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/e/b/seborrheic_dermatitis_b_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Seborrheic Dermatitis" loading="lazy"> </span> </a> </span> </span></b> is also common.</p></div> </div> </section> <section id="v1043627" class="topic__section FHead"> <h2 id="Diagnosis_v1043628" class="topic__header--section" data-originaltitle="Diagnosis"> <span id="v1043628" class="anchor"></span> Diagnosis of Parkinson Disease </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1043632" class="anchor"></span><div class="para"> <p>Mainly clinical evaluation, based on motor symptoms</p></div></li></ul></div><span id="v1043633" class="anchor"></span><div class="para"> <p>Diagnosis of Parkinson disease is clinical. Parkinson disease is suspected in patients with characteristic unilateral resting tremor, decreased movement, or rigidity. During finger-to-nose coordination testing, the tremor disappears (or attenuates) in the limb being tested.</p></div><span id="v1043634" class="anchor"></span><div class="para"> <p>During the neurologic examination, patients cannot perform rapidly alternating or rapid successive movements well. Sensation and strength are usually normal. Reflexes are normal but may be difficult to elicit because of marked tremor or rigidity.</p></div><span id="v1043637" class="anchor"></span><div class="para"> <p>Slowed and decreased movement due to Parkinson disease must be differentiated from decreased movement and spasticity due to lesions of the corticospinal tracts. Unlike Parkinson disease, corticospinal tract lesions cause</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v8305933" class="anchor"></span><div class="para"> <p>Paresis (weakness or paralysis), preferentially in distal antigravity muscles</p></div></li><li class="topic__listitem"><span id="v8305935" class="anchor"></span><div class="para"> <p>Hyperreflexia</p></div></li><li class="topic__listitem"><span id="v8305937" class="anchor"></span><div class="para"> <p>Extensor plantar responses (Babinski sign) </p></div></li><li class="topic__listitem"><span id="v8305939" class="anchor"></span><div class="para"> <p>Spasticity that increases muscle tone in proportion to the rate and degree of stretch placed on a muscle until resistance suddenly melts away (clasp-knife phenomenon)</p></div></li></ul></div><span id="v1043642" class="anchor"></span><div class="para"> <p>The diagnosis of Parkinson disease is supported by the presence of other signs such as infrequent blinking, lack of facial expression, and gait abnormalities. Postural instability is also present, but if it occurs early in the disease, clinicians should consider other possible diagnoses.</p></div><span id="v21505068" class="anchor"></span><div class="para"> <p>In older adults, other possible causes of decreased spontaneous movements or a short-stepped gait, such as severe depression, hypothyroidism, or use of antipsychotics or certain antiemetics, must be excluded before Parkinson disease is diagnosed.</p></div><span id="v1043644" class="anchor"></span><div class="para"> <p>To help distinguish Parkinson disease from secondary or atypical parkinsonism, clinicians often test responsiveness to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span>. A large, sustained response strongly supports Parkinson disease. A modest or no response to <span class="genericDrug" data-showrollover="false">levodopa</span> at doses of at least 1200 mg/day suggests another form of parkinsonism. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dopamine</span> ligand imaging can help distinguish between Parkinson disease (abnormal imaging findings) and drug-induced parkinsonism (normal imaging findings) or essential tremor (normal imaging findings). However, this imaging cannot discriminate between different types of degenerative parkinsonism such as Parkinson disease and dementia with Lewy bodies.</p></div><span id="v88079798" class="anchor"></span><div class="para"> <p>Causes of <a href="./{670C3BCD-FC33-45EC-8533-50441F1E9E1C}.html#v21505304" data-toggle="tooltip" title="Diagnosis" data-id="2c1efc7d-cf9c-49bf-bce5-a6edba68bf27" data-itemid="670c3bcd-fc33-45ec-8533-50441f1e9e1c">secondary or atypical parkinsonism</a><span id="2c1efc7d-cf9c-49bf-bce5-a6edba68bf27" class="d-none xref"> <span class="tooltip-container"> <a href="./{670C3BCD-FC33-45EC-8533-50441F1E9E1C}.html#v21505304"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis </span> Secondary parkinsonism refers to a group of disorders that have features similar to those of Parkinson disease but have a different etiology. Atypical parkinsonism refers to a group of neurodegenerative... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> can be identified by</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1043647" class="anchor"></span><div class="para"> <p>A thorough history, including occupational, medication, and family history</p></div></li><li class="topic__listitem"><span id="v1043649" class="anchor"></span><div class="para"> <p>Evaluation for neurologic deficits characteristic of disorders other than Parkinson disease </p></div></li><li class="topic__listitem"><span id="v1043651" class="anchor"></span><div class="para"> <p>Neuroimaging when patients have atypical features (eg, early falls, early cognitive impairment, ideomotor apraxia [inability to imitate hand gestures], hyperreflexia)</p></div></li></ul></div> </div> </section> <section id="v1043652" class="topic__section FHead" itemprop="possibleTreatment" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Treatment_v1043653" class="topic__header--section" data-originaltitle="Treatment"> <span id="v1043653" class="anchor"></span> Treatment of Parkinson Disease </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1043657" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Carbidopa/levodopa</span> (mainstay of treatment)</p></div></li><li class="topic__listitem"><span id="v1043659" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Amantadine</span>, MAO type B (MAO-B) inhibitors, or, in few patients, anticholinergic medications</p></div></li><li class="topic__listitem"><span id="v1043661" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Dopamine</span> agonists</p></div></li><li class="topic__listitem"><span id="v1043663" class="anchor"></span><div class="para"> <p>Catechol <i>O</i>-methyltransferase (COMT) inhibitors, always used with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span>, particularly when response to <span class="genericDrug" data-showrollover="false">levodopa</span> is wearing off </p></div></li><li class="topic__listitem"><span id="v1043665" class="anchor"></span><div class="para"> <p>Surgery if medications do not sufficiently control symptoms or have intolerable adverse effects </p></div></li><li class="topic__listitem"><span id="v1043667" class="anchor"></span><div class="para"> <p>Exercise and adaptive measures</p></div></li></ul></div><span id="v1043668" class="anchor"></span><div class="para"> <p>Many oral medications are commonly used to relieve symptoms of Parkinson disease ([ <a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v29590250" data-toggle="tooltip" title="Treatment references" data-id="1e07d816-dd79-420f-afe8-c432dafe70ec" data-itemid="95464a3a-ff18-49ec-9276-e37b55bcadc7">1</a><span id="1e07d816-dd79-420f-afe8-c432dafe70ec" class="d-none xref"> <span class="tooltip-container"> <a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v29590250"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Parkinson disease is a slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity), slow and decreased movement (bradykinesia), and eventually gait and/or... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>]; see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"cbf7ac9e-faca-457d-89eb-a8fe5c5c608e","Title":"Some%20Commonly%20Used%20Oral%20Antiparkinsonian%20Medications","ShareUrlTitle":"some-commonly-used-oral-antiparkinsonian-medications","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55490836","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ESome%20Commonly%20Used%20Oral%20Antiparkinsonian%20Medications%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>).</p></div><span id="v21505070" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Levodopa</span></b> is the most effective treatment. However, when Parkinson disease becomes severe, sometimes soon after diagnosis, response to <span class="genericDrug" data-showrollover="false">levodopa</span> can wear off, causing fluctuations in motor symptoms and dyskinesias (see <a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v1043681" data-toggle="tooltip" title="Levodopa" data-id="2346c195-d582-4a38-857b-6d2966f41998" data-itemid="95464a3a-ff18-49ec-9276-e37b55bcadc7">below</a><span id="2346c195-d582-4a38-857b-6d2966f41998" class="d-none xref"> <span class="tooltip-container"> <a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v1043681"> <span class="tooltip-content"> <span class="tooltip-heading"> Levodopa </span> <span class="tooltip-readmore"> </span> </span> </a> </span> </span>). To reduce the time <span class="genericDrug" data-showrollover="false">levodopa</span> is taken and thus minimize these effects, clinicians can consider treating younger patients who have mild disability with the following medications first:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v21505074" class="anchor"></span><div class="para"> <p>MAO-B inhibitors (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>selegiline</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rasagiline</span>)</p></div></li><li class="topic__listitem"><span id="v21505076" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Dopamine</span> agonists (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pramipexole</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ropinirole</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rotigotine</span>)</p></div></li><li class="topic__listitem"><span id="v21505078" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Amantadine</span> (which is also the best option when trying to decrease peak-dose dyskinesias)</p></div></li></ul></div><span id="v21505079" class="anchor"></span><div class="para"> <p>However, if these medications do not sufficiently control symptoms, clinicians should promptly initiate <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span> because it can usually greatly improve quality of life. Evidence now suggests that <span class="genericDrug" data-showrollover="false">levodopa</span> becomes ineffective because of disease progression rather than cumulative exposure to <span class="genericDrug" data-showrollover="false">levodopa</span>, as was previously believed, so early use of <span class="genericDrug" data-showrollover="false">levodopa</span> probably does not hasten its ineffectiveness.</p></div><span id="v1043670" class="anchor"></span><div class="para"> <p>Doses are often reduced in older adults. Medications that cause or worsen symptoms, particularly antipsychotics, are avoided.</p></div> <section id="v1043671" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1043653_v1043672" class="topic__header--subsection"> <span id="v1043672" class="anchor"></span> Levodopa </h3> <div class="topic__content"> <span id="v1043674" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Levodopa</span>, the metabolic precursor of <span class="genericDrug" data-showrollover="false">dopamine</span>, crosses the blood-brain barrier into the basal ganglia, where it is decarboxylated to form <span class="genericDrug" data-showrollover="false">dopamine</span>. Coadministration of the peripheral decarboxylase inhibitor <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carbidopa</span> prevents <span class="genericDrug" data-showrollover="false">levodopa</span> from being decarboxylated into <span class="genericDrug" data-showrollover="false">dopamine</span> outside the brain (peripherally), thus lowering the <span class="genericDrug" data-showrollover="false">levodopa</span> dosage required to produce therapeutic levels in the brain and minimizing adverse effects due to <span class="genericDrug" data-showrollover="false">dopamine</span> in the peripheral circulation. </p></div><span id="v8305942" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Levodopa</span> is most effective at relieving bradykinesia and rigidity and often substantially reduces tremor (<a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v29590250" data-toggle="tooltip" title="Treatment references" data-id="6ef35cb1-ddf0-47be-a8a9-b51c87260495" data-itemid="95464a3a-ff18-49ec-9276-e37b55bcadc7">2</a><span id="6ef35cb1-ddf0-47be-a8a9-b51c87260495" class="d-none xref"> <span class="tooltip-container"> <a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v29590250"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Parkinson disease is a slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity), slow and decreased movement (bradykinesia), and eventually gait and/or... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v1043675" class="anchor"></span><div class="para"> <p><b>Common short-term adverse effects</b> of <span class="genericDrug" data-showrollover="false">levodopa</span> are </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v8305945" class="anchor"></span><div class="para"> <p>Nausea</p></div></li><li class="topic__listitem"><span id="v8305947" class="anchor"></span><div class="para"> <p>Vomiting</p></div></li><li class="topic__listitem"><span id="v8305949" class="anchor"></span><div class="para"> <p>Light-headedness</p></div></li></ul></div><span id="v8305950" class="anchor"></span><div class="para"> <p><b>Common long-term adverse effects</b> include </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v8305953" class="anchor"></span><div class="para"> <p>Mental and psychiatric abnormalities (eg, delirium with confusion, psychoses, paranoia, visual hallucinations, punding [complex, repetitive, stereotyped behaviors]) </p></div></li><li class="topic__listitem"><span id="v8305955" class="anchor"></span><div class="para"> <p>Motor dysfunction (eg, dyskinesias, motor fluctuations)</p></div></li></ul></div><span id="v8305956" class="anchor"></span><div class="para"> <p>Hallucinations and paranoia occur most often in older adults and in patients who have cognitive impairment or dementia. </p></div><span id="v8305957" class="anchor"></span><div class="para"> <p>The dose that causes dyskinesias tends to decrease as the disease progresses. Over time, the dose that is needed for therapeutic benefit and the one that causes dyskinesia converge.</p></div><span id="v1043676" class="anchor"></span><div class="para"> <p>Dosage of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carbidopa/levodopa</span> is increased every 4 to 7 days as tolerated until maximum benefit is reached or adverse effects develop. The risk of adverse effects may be minimized by starting at a low dose, such as half of a 25/100 mg of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carbidopa/levodopa</span> tablet 3 or 4 times a day (12.5/50 mg 3 or 4 times a day), and increasing the dosage slowly to about one 25/100-mg tablets up to 4 times a day. Based on the patient's tolerance and response, clinicians can increase the dosage every week up to 2 or 3 tablets 4 times a day. In less common circumstances, the dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span> may be increased up to 3 tablets 5 times a day. Most patients with Parkinson disease require 400 to 1200 mg a day of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span> in divided doses every 2 to 5 hours.</p></div><span id="v48480762" class="anchor"></span><div class="para"> <p>Preferably, <span class="genericDrug" data-showrollover="false">levodopa</span> should not be given with food because protein can reduce absorption of <span class="genericDrug" data-showrollover="false">levodopa</span>. Four to 5 doses of <span class="genericDrug" data-showrollover="false">levodopa</span> a day are recommended to decrease the effect of fluctuating plasma levels of <span class="genericDrug" data-showrollover="false">levodopa</span> on different basal ganglia, which, can cause motor fluctuations and dyskinesias.</p></div><span id="v29590238" class="anchor"></span><div class="para"> <p>If peripheral adverse effects of <span class="genericDrug" data-showrollover="false">levodopa</span> (eg, nausea, vomiting, postural light-headedness) predominate, increasing the amount of <span class="genericDrug" data-showrollover="false">carbidopa</span> may help. <span class="genericDrug" data-showrollover="false">Carbidopa</span> doses up to 150 mg are safe and do not decrease the efficacy of <span class="genericDrug" data-showrollover="false">levodopa</span>.</p></div><span id="v48480763" class="anchor"></span><div class="para"> <p>Domperidone can be used to treat the adverse effects of <span class="genericDrug" data-showrollover="false">levodopa</span> (and other antiparkinsonian medications). It blocks peripheral <span class="genericDrug" data-showrollover="false">dopamine</span> receptors and does not cross the blood-brain barrier to affect the brain. By decreasing the decarboxylation of <span class="genericDrug" data-showrollover="false">levodopa</span> to <span class="genericDrug" data-showrollover="false">dopamine</span>, domperidone lessens the peripheral adverse effects of <span class="genericDrug" data-showrollover="false">levodopa</span>, thereby decreasing nausea, vomiting, and orthostatic hypotension. The recommended dosages are</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v48480766" class="anchor"></span><div class="para"> <p>Immediate-release: 10 mg orally 3 times a day, increased up to 20 mg 3 times a day if needed </p></div></li><li class="topic__listitem"><span id="v48480768" class="anchor"></span><div class="para"> <p>Sustained-release: 30 to 60 mg once in the morning (this dose may be enough to control <span class="genericDrug" data-showrollover="false">levodopa</span>'s peripheral adverse effects)</p></div></li></ul></div><span id="v48480769" class="anchor"></span><div class="para"> <p>Domperidone is not routinely available in the United States.</p></div><span id="v8305958" class="anchor"></span><div class="para"> <p>A dissolvable immediate-release oral form of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carbidopa/levodopa</span> can be taken without water; this form is useful for patients who have difficulty swallowing. Doses are the same as for nondissolvable immediate-release <span class="genericDrug" data-showrollover="false">carbidopa/levodopa</span>.</p></div><span id="v21505080" class="anchor"></span><div class="para"> <p>A controlled-release preparation of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carbidopa/levodopa</span> is available; however, it is usually used only to treat nighttime symptoms because when taken with food, it can be absorbed erratically and it is present longer in the stomach than immediate-release forms.</p></div><span id="v48480770" class="anchor"></span><div class="para"> <p>New forms of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span> delivery are available or being developed, but none has yet been shown to be superior to immediate-release <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carbidopa/levodopa</span> 25/100 mg.</p></div><span id="v1043678" class="anchor"></span><div class="para"> <p>Occasionally, <span class="genericDrug" data-showrollover="false">levodopa</span> must be used to maintain motor function despite <span class="genericDrug" data-showrollover="false">levodopa</span>-induced hallucinations or delirium. In such cases, hallucinations and delirium can be treated with medications. </p></div><span id="v21505081" class="anchor"></span><div class="para"> <p><b>Psychosis</b> has been treated with oral <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quetiapine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clozapine</span>; these medication, unlike other antipsychotics (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>risperidone</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>olanzapine</span>, all typical psychotics), do not aggravate parkinsonian symptoms. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quetiapine</span> can be started at 25 mg at night and increased in 25-mg increments every 1 to 3 days up to 400 mg at night or 200 2 times a day. Although <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clozapine</span> is most effective, its use is limited because agranulocytosis is a risk (estimated to occur in 1% of patients). When <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clozapine</span> is used, the dose is 12.5 to 50 mg once a day to 12.5 to 25 mg 2 times a day. A complete blood count (CBC) is done weekly for 6 months and every 2 weeks for another 6 months and then every 4 week thereafter. However, the frequency may vary depending on the white blood cell (WBC) count. Evidence suggests that <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pimavanserin</span> is efficacious for psychotic symptoms and does not aggravate parkinsonian symptoms; also medication monitoring does not appear necessary (<a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v29590250" data-toggle="tooltip" title="Treatment references" data-id="b40a6f47-a4c9-4fc8-a459-7237600e1dc1" data-itemid="95464a3a-ff18-49ec-9276-e37b55bcadc7">3</a><span id="b40a6f47-a4c9-4fc8-a459-7237600e1dc1" class="d-none xref"> <span class="tooltip-container"> <a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v29590250"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Parkinson disease is a slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity), slow and decreased movement (bradykinesia), and eventually gait and/or... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Pending further confirmation of efficacy and safety, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pimavanserin</span> may become the medication of choice for psychosis in Parkinson disease.</p></div><span id="v1043681" class="anchor"></span><div class="para"> <p>After 2 to 5 years of treatment, most patients experience fluctuations in their response to <span class="genericDrug" data-showrollover="false">levodopa</span>, and symptom control may fluctuate unpredictably between effective and ineffective (on-off fluctuations), as response to <span class="genericDrug" data-showrollover="false">levodopa</span> starts to wear off. Symptoms may occur before the next scheduled dose (called off effects). The dyskinesias and off effects result from a combination of the pharmacokinetic properties of <span class="genericDrug" data-showrollover="false">levodopa</span> (particularly its short half-life as an oral medication), and disease progression. </p></div><span id="v48480771" class="anchor"></span><div class="para"> <p>Early in Parkinson disease, there are enough surviving neurons to buffer any oversaturation of dopaminergic receptors in the substantia nigra. As a result, dyskinesias are less likely to occur, and <span class="genericDrug" data-showrollover="false">levodopa</span>'s therapeutic effect lasts longer because of the reuptake of excessive <span class="genericDrug" data-showrollover="false">levodopa</span> and its reutilization. As dopaminergic neurons are further depleted, each dose of <span class="genericDrug" data-showrollover="false">levodopa</span> saturates more and more <span class="genericDrug" data-showrollover="false">dopamine</span> receptors, resulting in dyskinesias and motor fluctuations because the delivery of <span class="genericDrug" data-showrollover="false">levodopa</span> to the substantia nigra becomes dependent on the plasma half life of <span class="genericDrug" data-showrollover="false">levodopa</span> (1.5 to 2 hours).</p></div><span id="v21505084" class="anchor"></span><div class="para"> <p>However, dyskinesias result mainly from disease progression and are not directly related to cumulative exposure to <span class="genericDrug" data-showrollover="false">levodopa</span>, as previously believed. Disease progression is associated with pulsatile administration of oral <span class="genericDrug" data-showrollover="false">levodopa</span>, which sensitizes and changes glutamatergic receptors, especially NMDA (<i>N</i>-methyl-<span data-mmanualobjecttype='smallcaps' class='smallcaps'>d</span>-aspartate) receptors. Eventually, the period of improvement after each dose shortens, and drug-induced dyskinesias result in swings from akinesia to dyskinesias. Traditionally, such swings are managed by keeping the <span class="genericDrug" data-showrollover="false">levodopa</span> dose as low as possible and using dosing intervals as short as every 1 to 2 hours, which are impractical. Alternative methods to decrease the off (akinetic) times include adjunctive use of <span class="genericDrug" data-showrollover="false">dopamine</span> agonists, as well as COMT and/or MAO inhibitors; <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>amantadine</span> may help manage dyskinesias.</p></div><span id="v8305959" class="anchor"></span><div class="para"> <p>A formulation of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span>/<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carbidopa</span> intestinal gel can be given using a pump connected to a feeding tube inserted in the proximal small bowel. This formulation is used as treatment for patients who have severe motor fluctuations and/or dyskinesias that cannot be relieved by medications and who are not candidates for deep brain stimulation. </p></div> </div> </section> <section id="v1043682" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1043653_v1043683" class="topic__header--subsection"> <span id="v1043683" class="anchor"></span> Amantadine </h3> <div class="topic__content"> <span id="v1043685" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Amantadine</span> is most often used to do the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v21505087" class="anchor"></span><div class="para"> <p>Ameliorate dyskinesias secondary to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span> </p></div></li><li class="topic__listitem"><span id="v21505089" class="anchor"></span><div class="para"> <p>Lessen tremors</p></div></li></ul></div><span id="v21505090" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Amantadine</span> is useful as monotherapy for early, mild parkinsonism and later can be used to augment <span class="genericDrug" data-showrollover="false">levodopa</span>’s effects. It may augment dopaminergic activity, anticholinergic effects, or both. <span class="genericDrug" data-showrollover="false">Amantadine</span> is also an NMDA-receptor antagonist and thus may help slow the progression of Parkinson disease and dyskinesias. If used as monotherapy, <span class="genericDrug" data-showrollover="false">amantadine</span> often loses its effectiveness after several months.</p></div> </div> </section> <section id="v1043686" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1043653_v1043687" class="topic__header--subsection"> <span id="v1043687" class="anchor"></span> Dopamine agonists </h3> <div class="topic__content"> <span id="v1043691" class="anchor"></span><div class="para"> <p>These medications directly activate <span class="genericDrug" data-showrollover="false">dopamine</span> receptors in the basal ganglia. They include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v21505093" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pramipexole</span></p></div></li><li class="topic__listitem"><span id="v21505095" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ropinirole</span></p></div></li><li class="topic__listitem"><span id="v21505097" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rotigotine</span></p></div></li><li class="topic__listitem"><span id="v21505099" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apomorphine</span></p></div></li></ul></div><span id="v1043692" class="anchor"></span><div class="para"> <p><b>Oral <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dopamine</span> agonists</b> can be used as monotherapy but, as such, are rarely effective for more than a few years. Using these medications early in treatment, with small doses of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span>, may be useful in patients at high risk of dyskinesias and on-off effects (eg, in patients < 60 years). However, <span class="genericDrug" data-showrollover="false">dopamine</span> agonists may be useful at all stages of the disease, including as adjunctive therapy in later stages. Adverse effects may limit the use of oral <span class="genericDrug" data-showrollover="false">dopamine</span> agonists. In 1 to 2% of patients, these medications may cause compulsive gambling, excessive shopping, hypersexuality, or overeating, requiring dose reduction or withdrawal of the causative medication and possibly avoidance of the medication class.</p></div><span id="v41282714" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pramipexole</span></b> and <b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ropinirole</span></b>, given orally, can be used instead of or with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span> in early Parkinson disease or, if necessary and not contraindicated, can be added to treatment in advanced disease. These medications have a half-life of 6 to 12 hours and can be taken as immediate-release preparations 3 times a day. They can also be taken as sustained-release preparations once/day, helping minimize peaks and troughs in blood levels. Daytime sleepiness is a common adverse effect.</p></div><span id="v1043693" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rotigotine</span></b>, given transdermally once a day, provides more continuous dopaminergic stimulation than medications given via other routes. Dose starts at 2 mg once a day and is usually increased to 6 mg once a day. Outside the United States, higher doses (8 mg) may be recommended.</p></div><span id="v1043696" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apomorphine</span></b> is a<span class="genericDrug" data-showrollover="false">dopamine</span> agonist used as rescue therapy when akinetic-rigid motor fluctuations are frequent and severe. It can be given sublingually or subcutaneously. Onset of action is rapid (5 to 10 minutes), but duration is short (60 to 90 minutes). <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apomorphine</span> can be given up to 5 times a day as needed. A 2-mg test dose is given first to check for <a href="./{E13E2DEC-3994-4ABB-A0BE-891827685991}.html" data-toggle="tooltip" title="Orthostatic Hypotension" data-id="99299674-29d3-4928-a1e6-e6a01dc605c1" data-itemid="e13e2dec-3994-4abb-a0be-891827685991">orthostatic hypotension</a><span id="99299674-29d3-4928-a1e6-e6a01dc605c1" class="d-none xref"> <span class="tooltip-container"> <a href="./{E13E2DEC-3994-4ABB-A0BE-891827685991}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Orthostatic Hypotension </span> Orthostatic (postural) hypotension is an excessive fall in blood pressure (BP) when an upright position is assumed. The consensus definition is a drop of > 20 mm Hg systolic, > 10 mm Hg... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Blood pressure (BP) is checked in the supine and standing positions before treatment and 20, 40, and 60 minutes afterward. Other adverse effects are similar to those of other <span class="genericDrug" data-showrollover="false">dopamine</span> agonists. Nausea can be prevented by starting <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>trimethobenzamide</span> 300 mg orally 3 times a day 3 days before starting <span class="genericDrug" data-showrollover="false">apomorphine</span> and continuing <span class="genericDrug" data-showrollover="false">trimethobenzamide</span> for the first 2 months of treatment.</p></div><span id="v21505102" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Apomorphine</span> given by subcutaneous pump is available in some countries; it can be used instead of a <span class="genericDrug" data-showrollover="false">levodopa</span> pump in patients who have advanced Parkinson disease and who are not candidates for functional surgery. </p></div><span id="v88079804" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bromocriptine</span> may be used in some countries, but in North America, its use is largely limited to treatment of pituitary adenomas because it increases the risk of cardiac valve fibrosis and pleural fibrosis.</p></div><span id="v88079805" class="anchor"></span><div class="para"> <p>Pergolide, an older ergot-derived <span class="genericDrug" data-showrollover="false">dopamine</span> agonist, was taken off the market because it increased the risk of cardiac valve fibrosis.</p></div> </div> </section> <section id="v1043698" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1043653_v1043699" class="topic__header--subsection"> <span id="v1043699" class="anchor"></span> Selective MAO-B inhibitors </h3> <div class="topic__content"> <span id="v1043702" class="anchor"></span><div class="para"> <p>Selective MAO-B inhibitors include <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>selegiline</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rasagiline</span>.</p></div><span id="v8305960" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Selegiline</span></b> inhibits one of the two major enzymes that break down <span class="genericDrug" data-showrollover="false">dopamine</span> in the brain, thereby prolonging the action of each dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span>. In some patients with mild off effects, <span class="genericDrug" data-showrollover="false">selegiline</span> helps prolong <span class="genericDrug" data-showrollover="false">levodopa</span>’s effectiveness. Used initially as monotherapy, <span class="genericDrug" data-showrollover="false">selegiline</span> controls mild symptoms; as a result, use of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span> can be delayed by about 1 year. A dose of 5 mg orally 2 times a day does not cause hypertensive crisis, which, because of the medication's <span class="genericDrug" data-showrollover="false">amphetamine</span>-like metabolites, is sometimes triggered when patients taking a nonselective MAO inhibitor consume tyramine in foods (eg, some cheeses). Although virtually free of adverse effects, <span class="genericDrug" data-showrollover="false">selegiline</span> can potentiate <span class="genericDrug" data-showrollover="false">levodopa</span>-induced dyskinesias, mental and psychiatric adverse effects, and nausea, requiring reduction in the <span class="genericDrug" data-showrollover="false">levodopa</span> dose. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Selegiline</span> is also available in a formulation designed for buccal absorption (zydis-<span class="genericDrug" data-showrollover="false">selegiline</span>).</p></div><span id="v1043703" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rasagiline</span></b> inhibits the same enzymes as <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>selegiline</span>. It is effective and well-tolerated in early and late disease; uses of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rasagiline</span> 1 mg orally once a day are similar to those of <span class="genericDrug" data-showrollover="false">selegiline</span>. Unlike <span class="genericDrug" data-showrollover="false">selegiline</span>, it does not have <span class="genericDrug" data-showrollover="false">amphetamine</span>-like metabolites, so theoretically, risk of a hypertensive crisis when patients consume tyramine is lower with <span class="genericDrug" data-showrollover="false">rasagiline</span>.</p></div> </div> </section> <section id="v1043705" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1043653_v1043706" class="topic__header--subsection"> <span id="v1043706" class="anchor"></span> Anticholinergic medications </h3> <div class="topic__content"> <span id="v1043710" class="anchor"></span><div class="para"> <p>Anticholinergic medications can be used as monotherapy in early Parkinson disease and later to supplement <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span>. They are most effective for tremor. Doses are increased very slowly. Adverse effects may include cognitive impairment and dry mouth, which are particularly troublesome for older adults and may be the principal problem with use of these medications. Thus, anticholinergic medications are usually used only in young patients with tremor-predominant Parkinson disease or with some dystonic components. Rarely, they are used as adjunctive treatment in older adults without cognitive impairment or psychiatric disorders.</p></div><span id="v29590239" class="anchor"></span><div class="para"> <p>Some studies using a mouse model indicate that use of anticholinergic medications should be limited because they appear to increase tau pathology and neurodegeneration; degree of increase correlates with the medication's central anticholinergic activity (<a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v29590250" data-toggle="tooltip" title="Treatment references" data-id="669498ed-395a-499b-87be-410ad7f3cd0f" data-itemid="95464a3a-ff18-49ec-9276-e37b55bcadc7">4</a><span id="669498ed-395a-499b-87be-410ad7f3cd0f" class="d-none xref"> <span class="tooltip-container"> <a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v29590250"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Parkinson disease is a slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity), slow and decreased movement (bradykinesia), and eventually gait and/or... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v29590250" data-toggle="tooltip" title="Treatment references" data-id="e2f0ac00-8ecd-4285-b20a-41cd96480673" data-itemid="95464a3a-ff18-49ec-9276-e37b55bcadc7">5</a><span id="e2f0ac00-8ecd-4285-b20a-41cd96480673" class="d-none xref"> <span class="tooltip-container"> <a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v29590250"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Parkinson disease is a slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity), slow and decreased movement (bradykinesia), and eventually gait and/or... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v8305962" class="anchor"></span><div class="para"> <p>Commonly used anticholinergic medications include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v48480774" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Benztropine</span>: 0.5 mg at night up to 1 mg 2 times a day to 2 mg 3 times a day</p></div></li><li class="topic__listitem"><span id="v48480776" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trihexyphenidyl</span>: 1 mg 3 times a day up to 2 to 5 mg 3 times a day</p></div></li></ul></div><span id="v21505103" class="anchor"></span><div class="para"> <p>Antihistamines with anticholinergic effects (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>diphenhydramine</span> 25 to 50 mg 2 to 4 times a day, or phenadrine 50 mg orally once to 4 times a day) are occasionally useful for treating tremor.</p></div><span id="v21505110" class="anchor"></span><div class="para"> <p>Anticholinergic tricyclic antidepressants (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>amitriptyline</span> 10 to 150 mg orally at bedtime), if used for depression, may be useful as an adjunct to <span class="genericDrug" data-showrollover="false">levodopa</span>. </p></div> </div> </section> <section id="v1043717" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1043653_v1043718" class="topic__header--subsection"> <span id="v1043718" class="anchor"></span> Catechol <i>O</i>-methyltransferase (COMT) inhibitors </h3> <div class="topic__content"> <span id="v1043722" class="anchor"></span><div class="para"> <p>These medications (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>entacapone</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tolcapone</span>) inhibit the breakdown of <span class="genericDrug" data-showrollover="false">levodopa</span> and <span class="genericDrug" data-showrollover="false">dopamine</span> and therefore appear to be useful adjuncts to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span>. They are used commonly in patients who have been taking <span class="genericDrug" data-showrollover="false">levodopa</span> for a long time when response to <span class="genericDrug" data-showrollover="false">levodopa</span> is progressively wearing off at the end of dosing intervals (known as wearing-off effects),</p></div><span id="v8305969" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Entacapone</span></b> can be used in combination with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carbidopa</span>. For each dose of <span class="genericDrug" data-showrollover="false">levodopa</span> taken, 200 mg of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>entacapone</span> is given, to a maximum of 200 mg 8 times a day. </p></div><span id="v8305970" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tolcapone</span></b> is a more potent COMT inhibitor because it can cross the blood-brain barrier; however, it is less commonly used because rarely, liver toxicity has been reported. It is an appropriate option if <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>entacapone</span> does not sufficiently control off effects. The dose for <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tolcapone</span> is increased gradually from 100 up to 200 mg 3 times a day. Liver enzymes must be monitored periodically. <span class="genericDrug" data-showrollover="false">Tolcapone</span> should be stopped if alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels increase to twice the upper limit of the normal range or higher or if symptoms and signs suggest that the liver is damaged. </p></div><span id="v48480777" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Opicapone</span> is a newer third-generation COMT inhibitor that appears to be effective and safe in patients with Parkinson disease. Unlike <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tolcapone</span> and like <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>entacapone</span>, <span class="genericDrug" data-showrollover="false">opicapone</span> does not require monitoring with periodic laboratory tests or multiple oral dosing. Recommended dose is 50 mg at bedtime. </p></div> <span id="v55490835"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v55490837"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"cbf7ac9e-faca-457d-89eb-a8fe5c5c608e","Title":"Some%20Commonly%20Used%20Oral%20Antiparkinsonian%20Medications","ShareUrlTitle":"some-commonly-used-oral-antiparkinsonian-medications","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55490836","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Some%20Commonly%20Used%20Oral%20Antiparkinsonian%20Medications","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="cbf7ac9e-faca-457d-89eb-a8fe5c5c608e"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'cbf7ac9e-faca-457d-89eb-a8fe5c5c608e' }, async: true, success: function (data) { $('#cbf7ac9e-faca-457d-89eb-a8fe5c5c608e').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> </div> </section> <section id="v1043910" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1043653_v1043911" class="topic__header--subsection"> <span id="v1043911" class="anchor"></span> Surgery </h3> <div class="topic__content"> <span id="v1043912" class="anchor"></span><div class="para"> <p>If pharmacotherapy is ineffective and/or has intolerable adverse effects, surgery, including deep brain stimulation and lesional surgery, may be considered.</p></div><span id="v8329475" class="anchor"></span><div class="para"> <p><b>Deep brain stimulation</b> of the subthalamic nucleus or globus pallidus interna is often recommended for patients with <span class="genericDrug" data-showrollover="false">levodopa</span>-induced dyskinesias or significant motor fluctuations; this procedure can modulate overactivity in the basal ganglia and thus decrease parkinsonian symptoms in patients with Parkinson disease. For patients with tremor only, stimulation of the ventralis intermediate nucleus of the thalamus is sometimes recommended; however, because most patients also have other symptoms, stimulation of the subthalamic nucleus, which relieves tremor as well as other symptoms, is usually preferred. When the main problem is inadequate control of dyskinesias or when patients have an increased risk of cognitive decline, the globus pallidus interna is a good target.</p></div><span id="v8329476" class="anchor"></span><div class="para"> <p><b>Lesional surgery</b> aims to stop overactivity directed to the thalamus from the globus pallidus interna; thalamotomy is sometimes done to control tremor in patients with tremor-predominant Parkinson disease. However, lesional surgery is not reversible and cannot be modulated over time; bilateral lesional surgery is not recommended because it can have severe adverse effects such as dysphagia and dysarthria. Lesional surgery involving the subthalamic nucleus is contraindicated because it causes severe ballismus.</p></div><span id="v48480813" class="anchor"></span><div class="para"> <p><b>Patient selection</b> is the most important factor for successful functional surgery in Parkinson disease. Surgery is usually considered when pharmacotherapy of dyskinesias and/or motor fluctuations is ineffective or severely limited. Pharmacotherapy may be inadequate because the medication has adverse effects that prevent further increases in the <span class="genericDrug" data-showrollover="false">levodopa</span> dose, which might lessen symptoms.</p></div><span id="v48480814" class="anchor"></span><div class="para"> <p>Other selection criteria include </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v48480817" class="anchor"></span><div class="para"> <p>Parkinson disease present for 5 to 15 years</p></div></li><li class="topic__listitem"><span id="v48480819" class="anchor"></span><div class="para"> <p>Patient age < 70 years</p></div></li><li class="topic__listitem"><span id="v48480821" class="anchor"></span><div class="para"> <p>No significant cognitive decline, no affective disorder, and, depending on life expectancy, no terminal disease (eg, cancer, chronic renal failure, liver failure, significant cardiopathy, uncontrolled diabetes mellitus or hypertension)</p></div></li></ul></div><span id="v8306008" class="anchor"></span><div class="para"> <p>Patients with cognitive impairment, dementia, or a psychiatric disorder are not suitable candidates for surgery because neurosurgery can exacerbate cognitive impairment and psychiatric disorders, and the risk of additional mental impairment outweighs the benefits of any improvement in motor function.</p></div> </div> </section> <section id="v29590246" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1043653_v29590247" class="topic__header--subsection"> <span id="v29590247" class="anchor"></span> High-intensity focused ultrasound (HIFU) </h3> <div class="topic__content"> <span id="v29590248" class="anchor"></span><div class="para"> <p>MR-guided high-intensity focused ultrasound can be used to control severe tremor refractory to medications in patients with Parkinson disease. With this procedure, the ventral intermediate nucleus of the thalamus can be ablated with minimal risk of hemorrhage and infection, which may occur when more invasive neurosurgical procedures are used.</p></div><span id="v48480822" class="anchor"></span><div class="para"> <p>In addition to tremor, HIFU has shown promise in treating symptoms of bradykinesia and rigidity while reducing the rate of dyskinesias (<a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v29590250" data-toggle="tooltip" title="Treatment references" data-id="dd112897-284f-4714-b17a-77b072bbe012" data-itemid="95464a3a-ff18-49ec-9276-e37b55bcadc7">6</a><span id="dd112897-284f-4714-b17a-77b072bbe012" class="d-none xref"> <span class="tooltip-container"> <a href="./{95464A3A-FF18-49EC-9276-E37B55BCADC7}.html#v29590250"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Parkinson disease is a slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity), slow and decreased movement (bradykinesia), and eventually gait and/or... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Although HIFU being less invasive than other surgical interventions, deep brain stimulation is favored by most expert clinicians.</p></div> </div> </section> <section id="v1043914" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1043653_v1043915" class="topic__header--subsection"> <span id="v1043915" class="anchor"></span> Physical measures </h3> <div class="topic__content"> <span id="v1043916" class="anchor"></span><div class="para"> <p>Maximizing activity is a goal. Patients should increase daily activities to the greatest extent possible. If they cannot, physical or occupational therapy, which may involve a regular exercise program, may help condition them physically. Therapists may teach patients adaptive strategies and help them make appropriate adaptations in the home (eg, installing grab bars to reduce the risk of falls).</p></div><span id="v1043917" class="anchor"></span><div class="para"> <p>To prevent or relieve constipation (which may result from Parkinson disease, antiparkinsonian medications, and/or inactivity), patients should consume a high-fiber diet, exercise when possible, and drink adequate amounts of fluids. Dietary supplements (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>psyllium</span>) and stimulant laxatives (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bisacodyl</span> 10 to 20 mg orally once a day) can help.</p></div> </div> </section> <section id="v21505117" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1043653_v21505118" class="topic__header--subsection"> <span id="v21505118" class="anchor"></span> Caregiver and end-of-life issues </h3> <div class="topic__content"> <span id="v21505119" class="anchor"></span><div class="para"> <p>Because Parkinson disease is progressive, patients eventually need help with normal daily activities. Caregivers should be directed to resources that can help them learn about the physical and psychologic effects of Parkinson disease and about ways to help the patient function as well as possible. Because such care is tiring and stressful, caregivers should be encouraged to contact support groups for social and psychologic support.</p></div><span id="v21505120" class="anchor"></span><div class="para"> <p>Eventually, most patients become severely disabled and immobile. They may be unable to eat, even with assistance. Because swallowing becomes increasingly difficult, death due to <a href="./{599F95A9-8993-4379-9861-5906FB92BE71}.html" data-toggle="tooltip" title="Aspiration Pneumonitis and Pneumonia" data-id="78d65f01-db29-4ca1-9ed9-d6781768e906" data-itemid="599f95a9-8993-4379-9861-5906fb92be71">aspiration pneumonia</a><span id="78d65f01-db29-4ca1-9ed9-d6781768e906" class="d-none xref"> <span class="tooltip-container"> <a href="./{599F95A9-8993-4379-9861-5906FB92BE71}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Aspiration Pneumonitis and Pneumonia </span> Aspiration pneumonitis and pneumonia are caused by inhaling toxic and/or irritant substances, most commonly large volumes of upper airway secretions or gastric contents, into the lungs. Chemical... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> is a risk. For some patients, a nursing home may be the best place for care.</p></div><span id="v21505122" class="anchor"></span><div class="para"> <p>Before people with Parkinson disease are incapacitated, they should establish <a href="./{30608D3A-CA38-4235-9778-B9CDA526592E}.html" data-toggle="tooltip" title="Advance Directives" data-id="93258f55-f2d1-4442-b46c-62dcb1ee9328" data-itemid="30608d3a-ca38-4235-9778-b9cda526592e">advance directives</a><span id="93258f55-f2d1-4442-b46c-62dcb1ee9328" class="d-none xref"> <span class="tooltip-container"> <a href="./{30608D3A-CA38-4235-9778-B9CDA526592E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Advance Directives </span> Advance directives are legal documents that extend a person's control over health care decisions in the event that the person becomes incapacitated. They are called advance directives because... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, indicating what kind of medical care they want at the end of life.</p></div> </div> </section> <section id="v29590249" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="Treatment_v1043653_v29590250" class="topic__header--subsection"> <span itemprop="name" id="v29590250" class="anchor"></span> Treatment references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v88079808" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.27372">Fox SH, Katzenschlager R, Lim S-Y, et al</a>: International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease. <span data-mmanualobjecttype="pubtitle">Mov Disord</span> 33 (8):1248–1266, 2018. doi: 10.1002/mds.27372 Epub 2018 Mar 23.</p></div></li><li class="topic__listitem"><span id="v88079812" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.nejm.org/doi/10.1056/NEJMoa033447?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov">Fahn S, Oakes D, Shoulson I, et al</a>: <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Levodopa</span> and the progression of Parkinson's disease. <span data-mmanualobjecttype="pubtitle">N Engl J Med</span> 351 (24):2498–2508, 2004. doi: 10.1056/NEJMoa033447</p></div></li><li class="topic__listitem"><span id="v88079816" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)62106-6/fulltext">Cummings J, Isaacson S, Mills R, et al</a>: <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pimavanserin</span> for patients with Parkinson's disease psychosis: A randomised, placebo-controlled phase 3 trial, <span data-mmanualobjecttype="pubtitle">Lancet</span> 383 (9916):533–540, 2014. doi: 10.1016/S0140-6736(13)62106-6</p></div></li><li class="topic__listitem"><span id="v29590253" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://www.sciencedirect.com/science/article/pii/S096999611100283X?via%3Dihub">Yoshiyama Y, Kojima A, Itoh K, Uchiyama T, Arai K</a>: Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model. <span data-mmanualobjecttype="pubtitle">Neurobiol Dis</span> 2012 45 (1):329–336, 2012. doi: 10.1016/j.nbd.2011.08.017</p></div></li><li class="topic__listitem"><span id="v41546603" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://www.karger.com/Article/FullText/381484">Yoshiyama Y, Kojima A, Itoh K, et al</a>: Does anticholinergic activity affect neuropathology? Implication of neuroinflammation in Alzheimer's disease. <span data-mmanualobjecttype="pubtitle">Neurodegener Dis</span> 15 (3):140-148, 2015. doi: 10.1159/000381484 </p></div></li><li class="topic__listitem"><span id="v88079820" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://www.nejm.org/doi/10.1056/NEJMoa2202721?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed">Vibhor KrishnaV, Paul S. Fishman PS, Eisenberg HM, et al</a>: Trial of globus pallidus focused ultrasound ablation in Parkinson's disease. <span data-mmanualobjecttype="pubtitle">N Engl J Med</span> 388 (8):683–693, 2023. doi: 10.1056/NEJMoa2202721</p></div></li></ul></div> </div> </section> </div> </section> <section id="v8306009" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v8306010" class="anchor"></span> Key Points </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v8306013" class="anchor"></span><div class="para"> <p>Parkinson disease is a synucleinopathy and thus can overlap with other synucleinopathies (eg, dementia with Lewy bodies, multiple system atrophy).</p></div></li><li class="topic__listitem"><span id="v8306015" class="anchor"></span><div class="para"> <p>Suspect Parkinson disease based on characteristic features: resting tremor, muscle rigidity, slow and decreased movement, and postural and gait instability.</p></div></li><li class="topic__listitem"><span id="v8306017" class="anchor"></span><div class="para"> <p>Distinguish Parkinson disease from disorders that cause similar symptoms based mainly on the history and physical examination results, but also test responsiveness to <span class="genericDrug" data-showrollover="false">levodopa</span>; sometimes neuroimaging is useful.</p></div></li><li class="topic__listitem"><span id="v8306019" class="anchor"></span><div class="para"> <p>Typically, use <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span>/<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carbidopa</span> (the mainstay of treatment), but other medications (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>amantadine</span>, <span class="genericDrug" data-showrollover="false">dopamine</span> agonists, MAO-B inhibitors, COMT inhibitors) may be used before and/or with <span class="genericDrug" data-showrollover="false">levodopa/carbidopa</span>.</p></div></li><li class="topic__listitem"><span id="v8306021" class="anchor"></span><div class="para"> <p>Consider surgical procedures, such as deep brain stimulation, if patients have symptoms refractory to optimal pharmacotherapy and do not have cognitive impairment or a psychiatric disorder.</p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="332.0">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: '332.0',
 title: 'Parkinson Disease',
 itemGuid: '95464a3a-ff18-49ec-9276-e37b55bcadc7'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{28DFE916-BB57-4592-8ACC-EAEE62CAADDF}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Myoclonus</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{670C3BCD-FC33-45EC-8533-50441F1E9E1C}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Secondary and Atypical Parkinsonism</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="6230c987-15a1-4f5a-9a9b-dfd42a8f0911_mobile" usemap="#6230c987-15a1-4f5a-9a9b-dfd42a8f0911_mobile" width="326" height="90">
 <map name="6230c987-15a1-4f5a-9a9b-dfd42a8f0911_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="6230c987-15a1-4f5a-9a9b-dfd42a8f0911_tablet" usemap="#6230c987-15a1-4f5a-9a9b-dfd42a8f0911_tablet" width="326" height="90">
 <map name="6230c987-15a1-4f5a-9a9b-dfd42a8f0911_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="6230c987-15a1-4f5a-9a9b-dfd42a8f0911_desktop" usemap="#6230c987-15a1-4f5a-9a9b-dfd42a8f0911_desktop" width="326" height="90">
 <map name="6230c987-15a1-4f5a-9a9b-dfd42a8f0911_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd02
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="95464A3AFF1849EC9276E37B55BCADC7">
<div id="hiddentblcontents" style="display:none"><div id='hidden_v55490836'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v55490837"></span> <div class="TableFullPage" id="v55490836"> <h3 class="title">Some Commonly Used Oral Antiparkinsonian Medications</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55490848" class="anchor"></span><div class="para"> <p>Medication</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55490854" class="anchor"></span><div class="para"> <p>Average Daily Dose and Maximum Dose When Applicable</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55490857" class="anchor"></span><div class="para"> <p>Major Adverse Effects</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v55490872" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Dopamine</span> precursors</p></div></p></td></tr><tr class="even"><td><span id="v55490875" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Carbidopa/levodopa</span> 10/100, 25/100, or 25/250 mg (immediate-release or dissolvable)</p></div></td><td><span id="v55490879" class="anchor"></span><div class="para"> <p>1–3 tablets of 25/100 mg 4 times a day </p></div></td><td rowspan="2"><span id="v55490881" class="anchor"></span><div class="para"> <p><b>Central:</b> Drowsiness, confusion, orthostatic hypotension, psychotic disturbances, nightmares, dyskinesia</p></div><span id="v55490882" class="anchor"></span><div class="para"> <p><b>Peripheral:</b> Nausea, anorexia, flushing abdominal cramping, constipation, palpitations</p></div><span id="v55490883" class="anchor"></span><div class="para"> <p><b>With sudden discontinuation:</b> Neuroleptic malignant syndrome</p></div></td></tr><tr class="odd"><td><span id="v55490886" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Carbidopa/levodopa</span> 25/100 or 50/200 mg (controlled-release; recommended only for nighttime [not daytime] symptoms)</p></div></td><td><span id="v55490890" class="anchor"></span><div class="para"> <p>1 or 2 tablets of 50/200 mg at bedtime</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v55490894" class="anchor"></span><div class="para"> <p>Antiviral medication</p></div></p></td></tr><tr class="odd"><td><span id="v55490897" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Amantadine</span></p></div></td><td><span id="v55490901" class="anchor"></span><div class="para"> <p>100 mg 2 times a day</p></div></td><td><span id="v55490903" class="anchor"></span><div class="para"> <p>Confusion, urinary retention, leg edema, elevated intraocular pressure, livedo reticularis</p></div><span id="v55490904" class="anchor"></span><div class="para"> <p><b>Rarely, with discontinuation or a decrease in dose:</b> Neuroleptic malignant syndrome</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v55490908" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Dopamine</span> agonists</p></div></p></td></tr><tr class="odd"><td><span id="v62054412" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apomorphine</span></p></div></td><td><span id="x000290" class="anchor"></span><div class="para"> <p>2 to 6 mg subcutaneously or 10–30 mg sublingually</p></div></td><td rowspan="4"><span id="v62054420" class="anchor"></span><div class="para"> <p>Nausea, vomiting, light-headedness (due to orthostatic hypotension), hallucinations, impulse control disorder (gambling, buying, excessive eating, collecting)</p></div><span id="v62054421" class="anchor"></span><div class="para"> <p>With the <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rotigotine</span> patch only, redness, itching, and swelling in the legs and at the application site</p></div></td></tr><tr class="even"><td><span id="x000286" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pramipexole</span></p></div></td><td><span id="v62054416" class="anchor"></span><div class="para"> <p>0.5–1 mg 3 times a day</p></div><span id="v62054417" class="anchor"></span><div class="para"> <p>Maximum dose: 4.5 mg/day</p></div><span id="v62054418" class="anchor"></span><div class="para"> <p>Extended-release formulation: Can be dosed once or twice a day</p></div></td></tr><tr class="odd"><td><span id="v62054424" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ropinirole</span></p></div></td><td><span id="v62054428" class="anchor"></span><div class="para"> <p>3–4 mg 3 times a day</p></div><span id="v62054429" class="anchor"></span><div class="para"> <p>Maximum dose: 24 mg a day</p></div><span id="v62054430" class="anchor"></span><div class="para"> <p>Extended-release formulation: Can be dosed once a day</p></div></td></tr><tr class="even"><td><span id="v62054433" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rotigotine</span></p></div></td><td><span id="v62054437" class="anchor"></span><div class="para"> <p>4, 6, or 8 mg a day in a patch applied daily</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v55490930" class="anchor"></span><div class="para"> <p>Anticholinergic medications*</p></div></p></td></tr><tr class="even"><td><span id="v55490933" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Benztropine</span></p></div></td><td><span id="v55490937" class="anchor"></span><div class="para"> <p>1 mg 2 times a day–2 mg 3 times a day</p></div></td><td rowspan="2"><span id="v55490939" class="anchor"></span><div class="para"> <p>Drowsiness, dry mouth, urinary retention, constipation, blurred vision</p></div><span id="v55490940" class="anchor"></span><div class="para"> <p><b>Particularly in older adults:</b> Confusion, delirium, impaired thermoregulation due to decreased sweating</p></div></td></tr><tr class="odd"><td><span id="v55490943" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trihexyphenidyl</span></p></div></td><td><span id="v55490947" class="anchor"></span><div class="para"> <p>2–5 mg 3 times a day</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v55490951" class="anchor"></span><div class="para"> <p>Monoamine oxidase type B (MAO-B) inhibitors</p></div></p></td></tr><tr class="odd"><td><span id="v55490954" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rasagiline</span></p></div></td><td><span id="v55490958" class="anchor"></span><div class="para"> <p>1 mg once a day</p></div></td><td><span id="v55490960" class="anchor"></span><div class="para"> <p>Nausea, insomnia, somnolence, edema</p></div></td></tr><tr class="even"><td><span id="v55490963" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Selegiline</span>†</p></div></td><td><span id="v55490967" class="anchor"></span><div class="para"> <p>5 mg 2 times a day, given with breakfast and lunch</p></div></td><td><span id="v55490969" class="anchor"></span><div class="para"> <p>Possible potentiation of nausea, insomnia, confusion, and dyskinesias when given with <span class="genericDrug" data-showrollover="false">levodopa</span></p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v55490973" class="anchor"></span><div class="para"> <p>Catechol <i>O</i>-methyltransferase (COMT) inhibitors</p></div></p></td></tr><tr class="even"><td><span id="v55490976" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Entacapone</span>‡</p></div></td><td><span id="v55490980" class="anchor"></span><div class="para"> <p>200 mg with each dose of <span class="genericDrug" data-showrollover="false">levodopa</span></p></div><span id="v55490981" class="anchor"></span><div class="para"> <p>Maximum dose: 200 mg 8 times a day</p></div></td><td rowspan="3"><span id="v55490983" class="anchor"></span><div class="para"> <p><b>Due to increased bioavailability of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span></b>: Dyskinesias, nausea, confusion, hallucinations</p></div><span id="v55490984" class="anchor"></span><div class="para"> <p><b>Unrelated to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span></b>: Back pain, diarrhea, changes in color of urine</p></div><span id="v55490985" class="anchor"></span><div class="para"> <p>With <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tolcapone</span>, risk of liver toxicity (rare)</p></div></td></tr><tr class="odd"><td><span id="v55490988" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Opicapone</span></p></div></td><td><span id="v55490992" class="anchor"></span><div class="para"> <p>50 mg at bedtime</p></div></td></tr><tr class="even"><td><span id="v55490995" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tolcapone</span></p></div></td><td><span id="v55490999" class="anchor"></span><div class="para"> <p>100–200 mg 3 times a day</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v55490861" class="anchor"></span><div class="para"> <p>* Anticholinergic medications should preferably not be used in older adults. Because these medications have adverse effects and because recent findings suggest that these medications may increase tau pathology and neurodegeneration, their use should be limited.</p></div></td></tr><tr><td colspan="3"><span id="v55490864" class="anchor"></span><div class="para"> <p>† <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Selegiline</span> is also available in a formulation designed for buccal absorption.</p></div></td></tr><tr><td colspan="3"><span id="v55490867" class="anchor"></span><div class="para"> <p>‡ <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Entacapone</span> is also available in a triple combination tablet (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carbidopa</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>entacapone</span>).</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></div><div id="hiddentblcontents" style="display:none"></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55490836'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v55490837"></span> <div class="TableFullPage" id="v55490836"> <h3 class="title">Some Commonly Used Oral Antiparkinsonian Medications</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55490848" class="anchor"></span><div class="para"> <p>Medication</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55490854" class="anchor"></span><div class="para"> <p>Average Daily Dose and Maximum Dose When Applicable</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55490857" class="anchor"></span><div class="para"> <p>Major Adverse Effects</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v55490872" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Dopamine</span> precursors</p></div></p></td></tr><tr class="even"><td><span id="v55490875" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Carbidopa/levodopa</span> 10/100, 25/100, or 25/250 mg (immediate-release or dissolvable)</p></div></td><td><span id="v55490879" class="anchor"></span><div class="para"> <p>1–3 tablets of 25/100 mg 4 times a day </p></div></td><td rowspan="2"><span id="v55490881" class="anchor"></span><div class="para"> <p><b>Central:</b> Drowsiness, confusion, orthostatic hypotension, psychotic disturbances, nightmares, dyskinesia</p></div><span id="v55490882" class="anchor"></span><div class="para"> <p><b>Peripheral:</b> Nausea, anorexia, flushing abdominal cramping, constipation, palpitations</p></div><span id="v55490883" class="anchor"></span><div class="para"> <p><b>With sudden discontinuation:</b> Neuroleptic malignant syndrome</p></div></td></tr><tr class="odd"><td><span id="v55490886" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Carbidopa/levodopa</span> 25/100 or 50/200 mg (controlled-release; recommended only for nighttime [not daytime] symptoms)</p></div></td><td><span id="v55490890" class="anchor"></span><div class="para"> <p>1 or 2 tablets of 50/200 mg at bedtime</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v55490894" class="anchor"></span><div class="para"> <p>Antiviral medication</p></div></p></td></tr><tr class="odd"><td><span id="v55490897" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Amantadine</span></p></div></td><td><span id="v55490901" class="anchor"></span><div class="para"> <p>100 mg 2 times a day</p></div></td><td><span id="v55490903" class="anchor"></span><div class="para"> <p>Confusion, urinary retention, leg edema, elevated intraocular pressure, livedo reticularis</p></div><span id="v55490904" class="anchor"></span><div class="para"> <p><b>Rarely, with discontinuation or a decrease in dose:</b> Neuroleptic malignant syndrome</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v55490908" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Dopamine</span> agonists</p></div></p></td></tr><tr class="odd"><td><span id="v62054412" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apomorphine</span></p></div></td><td><span id="x000290" class="anchor"></span><div class="para"> <p>2 to 6 mg subcutaneously or 10–30 mg sublingually</p></div></td><td rowspan="4"><span id="v62054420" class="anchor"></span><div class="para"> <p>Nausea, vomiting, light-headedness (due to orthostatic hypotension), hallucinations, impulse control disorder (gambling, buying, excessive eating, collecting)</p></div><span id="v62054421" class="anchor"></span><div class="para"> <p>With the <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rotigotine</span> patch only, redness, itching, and swelling in the legs and at the application site</p></div></td></tr><tr class="even"><td><span id="x000286" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pramipexole</span></p></div></td><td><span id="v62054416" class="anchor"></span><div class="para"> <p>0.5–1 mg 3 times a day</p></div><span id="v62054417" class="anchor"></span><div class="para"> <p>Maximum dose: 4.5 mg/day</p></div><span id="v62054418" class="anchor"></span><div class="para"> <p>Extended-release formulation: Can be dosed once or twice a day</p></div></td></tr><tr class="odd"><td><span id="v62054424" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ropinirole</span></p></div></td><td><span id="v62054428" class="anchor"></span><div class="para"> <p>3–4 mg 3 times a day</p></div><span id="v62054429" class="anchor"></span><div class="para"> <p>Maximum dose: 24 mg a day</p></div><span id="v62054430" class="anchor"></span><div class="para"> <p>Extended-release formulation: Can be dosed once a day</p></div></td></tr><tr class="even"><td><span id="v62054433" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rotigotine</span></p></div></td><td><span id="v62054437" class="anchor"></span><div class="para"> <p>4, 6, or 8 mg a day in a patch applied daily</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v55490930" class="anchor"></span><div class="para"> <p>Anticholinergic medications*</p></div></p></td></tr><tr class="even"><td><span id="v55490933" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Benztropine</span></p></div></td><td><span id="v55490937" class="anchor"></span><div class="para"> <p>1 mg 2 times a day–2 mg 3 times a day</p></div></td><td rowspan="2"><span id="v55490939" class="anchor"></span><div class="para"> <p>Drowsiness, dry mouth, urinary retention, constipation, blurred vision</p></div><span id="v55490940" class="anchor"></span><div class="para"> <p><b>Particularly in older adults:</b> Confusion, delirium, impaired thermoregulation due to decreased sweating</p></div></td></tr><tr class="odd"><td><span id="v55490943" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trihexyphenidyl</span></p></div></td><td><span id="v55490947" class="anchor"></span><div class="para"> <p>2–5 mg 3 times a day</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v55490951" class="anchor"></span><div class="para"> <p>Monoamine oxidase type B (MAO-B) inhibitors</p></div></p></td></tr><tr class="odd"><td><span id="v55490954" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rasagiline</span></p></div></td><td><span id="v55490958" class="anchor"></span><div class="para"> <p>1 mg once a day</p></div></td><td><span id="v55490960" class="anchor"></span><div class="para"> <p>Nausea, insomnia, somnolence, edema</p></div></td></tr><tr class="even"><td><span id="v55490963" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Selegiline</span>†</p></div></td><td><span id="v55490967" class="anchor"></span><div class="para"> <p>5 mg 2 times a day, given with breakfast and lunch</p></div></td><td><span id="v55490969" class="anchor"></span><div class="para"> <p>Possible potentiation of nausea, insomnia, confusion, and dyskinesias when given with <span class="genericDrug" data-showrollover="false">levodopa</span></p></div></td></tr><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v55490973" class="anchor"></span><div class="para"> <p>Catechol <i>O</i>-methyltransferase (COMT) inhibitors</p></div></p></td></tr><tr class="even"><td><span id="v55490976" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Entacapone</span>‡</p></div></td><td><span id="v55490980" class="anchor"></span><div class="para"> <p>200 mg with each dose of <span class="genericDrug" data-showrollover="false">levodopa</span></p></div><span id="v55490981" class="anchor"></span><div class="para"> <p>Maximum dose: 200 mg 8 times a day</p></div></td><td rowspan="3"><span id="v55490983" class="anchor"></span><div class="para"> <p><b>Due to increased bioavailability of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span></b>: Dyskinesias, nausea, confusion, hallucinations</p></div><span id="v55490984" class="anchor"></span><div class="para"> <p><b>Unrelated to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span></b>: Back pain, diarrhea, changes in color of urine</p></div><span id="v55490985" class="anchor"></span><div class="para"> <p>With <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tolcapone</span>, risk of liver toxicity (rare)</p></div></td></tr><tr class="odd"><td><span id="v55490988" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Opicapone</span></p></div></td><td><span id="v55490992" class="anchor"></span><div class="para"> <p>50 mg at bedtime</p></div></td></tr><tr class="even"><td><span id="v55490995" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tolcapone</span></p></div></td><td><span id="v55490999" class="anchor"></span><div class="para"> <p>100–200 mg 3 times a day</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v55490861" class="anchor"></span><div class="para"> <p>* Anticholinergic medications should preferably not be used in older adults. Because these medications have adverse effects and because recent findings suggest that these medications may increase tau pathology and neurodegeneration, their use should be limited.</p></div></td></tr><tr><td colspan="3"><span id="v55490864" class="anchor"></span><div class="para"> <p>† <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Selegiline</span> is also available in a formulation designed for buccal absorption.</p></div></td></tr><tr><td colspan="3"><span id="v55490867" class="anchor"></span><div class="para"> <p>‡ <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Entacapone</span> is also available in a triple combination tablet (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carbidopa</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>levodopa</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>entacapone</span>).</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>